RVL Pharmaceuticals: Q1 Earnings Insights


RVL Pharmaceuticals RVLP reported its Q1 earnings results on Thursday, May 11, 2023 at 06:50 AM.

Here's what investors need to know about the announcement.


RVL Pharmaceuticals reported in-line EPS of $-0.12 versus an estimate of $-0.12.

Revenue was down $12.61 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.11 which was followed by a 2.8% increase in the share price the next day.

Here's a look at RVL Pharmaceuticals's past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate -0.16 -0.16 -0.14 -0.21
EPS Actual -0.05 -0.16 -0.14 -0.08
Revenue Estimate 12.60M 10.22M 8.52M 7.44M
Revenue Actual 9.81M 10.02M 8.45M 21.44M

To track all earnings releases for RVL Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!